Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Non-Current Deferred Tax Liability (2025)

Adaptin Bio (APTN) posted Non-Current Deferred Tax Liability of $31.0 million for Q3 2025.

Adaptin Bio (APTN) Non-Current Deferred Tax Liability (2025) Analysis & Trends

Adaptin Bio has reported Non-Current Deferred Tax Liability for 1 years, with the latest figure at $31.0 million in Q3 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 31.00 Mn
Sep 30, 2025 31.00 Mn